Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1962 1
1963 4
1964 1
1965 1
1966 1
1974 1
1978 2
1979 4
1982 5
1983 2
1984 2
1985 4
1986 5
1987 9
1988 14
1989 9
1990 12
1991 17
1992 14
1993 10
1994 14
1995 26
1996 28
1997 40
1998 46
1999 44
2000 71
2001 47
2002 59
2003 70
2004 98
2005 104
2006 109
2007 111
2008 145
2009 177
2010 166
2011 193
2012 221
2013 221
2014 265
2015 292
2016 264
2017 274
2018 286
2019 336
2020 405
2021 477
2022 421
2023 390
2024 442
2025 427
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,734 results

Results by year

Filters applied: . Clear all
Page 1
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.
Ahn MJ, Tanaka K, Paz-Ares L, Cornelissen R, Girard N, Pons-Tostivint E, Vicente Baz D, Sugawara S, Cobo M, Pérol M, Mascaux C, Poddubskaya E, Kitazono S, Hayashi H, Hong MH, Felip E, Hall R, Juan-Vidal O, Brungs D, Lu S, Garassino M, Chargualaf M, Zhang Y, Howarth P, Uema D, Lisberg A, Sands J; TROPION-Lung01 Trial Investigators. Ahn MJ, et al. Among authors: hong mh. J Clin Oncol. 2025 Jan 20;43(3):260-272. doi: 10.1200/JCO-24-01544. Epub 2024 Sep 9. J Clin Oncol. 2025. PMID: 39250535 Free PMC article. Clinical Trial.
Editorial: Disabled people's health.
Park S, Park SY, Hong M, Osailan AM, Oh IH. Park S, et al. Among authors: hong m. Front Public Health. 2024 Sep 18;12:1485424. doi: 10.3389/fpubh.2024.1485424. eCollection 2024. Front Public Health. 2024. PMID: 39360253 Free PMC article. No abstract available.
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials.
Dawed AY, Mari A, Brown A, McDonald TJ, Li L, Wang S, Hong MG, Sharma S, Robertson NR, Mahajan A, Wang X, Walker M, Gough S, Hart LM', Zhou K, Forgie I, Ruetten H, Pavo I, Bhatnagar P, Jones AG, Pearson ER; DIRECT consortium. Dawed AY, et al. Among authors: hong mg. Lancet Diabetes Endocrinol. 2023 Jan;11(1):33-41. doi: 10.1016/S2213-8587(22)00340-0. Lancet Diabetes Endocrinol. 2023. PMID: 36528349 Free article.
Cohort Profile: South China Cohort.
Yang J, Luo S, Liu Y, Hong M, Qiu X, Lin Y, Zhang W, Gao P, Li Z, Hu Z, Xia M; South China Cohort (SCC) Collaborative Group. Yang J, et al. Among authors: hong m. Int J Epidemiol. 2024 Feb 14;53(2):dyae028. doi: 10.1093/ije/dyae028. Int J Epidemiol. 2024. PMID: 38412541 No abstract available.
Enhanced risk stratification for stage II colorectal cancer using deep learning-based CT classifier and pathological markers to optimize adjuvant therapy decision.
Huang YQ, Chen XB, Cui YF, Yang F, Huang SX, Li ZH, Ying YJ, Li SY, Li MH, Gao P, Wu ZQ, Wen G, Wang ZS, Wang HX, Hong MP, Diao WJ, Chen XY, Hou KQ, Zhang R, Hou J, Fang Z, Wang ZN, Mao Y, Wee L, Liu ZY. Huang YQ, et al. Among authors: hong mp. Ann Oncol. 2025 Oct;36(10):1178-1189. doi: 10.1016/j.annonc.2025.05.537. Epub 2025 Jun 4. Ann Oncol. 2025. PMID: 40480552 Free article.
5,734 results